Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02148276 · ClinicalTrials.gov registry record
Improving Identification of Social Harm Among Substance Abusers in HIV Trials
A clinical trial of Social Harms in Substance Users in HIV Trials and Audio Computer Assisted Self-administered Questionnaire, sponsored by Treatment Research Institute.
- Completed
- Registry status
- 79
- Enrollment target
- 1
- Study location
NCT02148276: Completed study of Social Harms in Substance Users in HIV Trials and Audio Computer Assisted Self-administered Questionnaire, sponsored by Treatment Research Institute.
NCT02148276 is a study of Social Harms in Substance Users in HIV Trials and Audio Computer Assisted Self-administered Questionnaire that has completed, run by Treatment Research Institute. The registered enrollment target is 79 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02148276, a study of Social Harms in Substance Users in HIV Trials and Audio Computer Assisted Self-administered Questionnaire, has completed, sponsored by Treatment Research Institute.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
This two-phased project will develop a comprehensive, audio computer assisted self-administered interview social harm questionnaire (ACASI-SHQ) that will allow researchers to more easily identify and monitor social harms experienced by substance abusers participating in HIV-related trials. The ACASI-SHQ will (1) reduce the likelihood of socially desirable responding, (2) include items with high levels of specificity to increase the likelihood of identifying social harms (construct validity), and (3) utilize a self-interview format that will increase the likelihood of its adoption by HIV researchers. The investigators will then evaluate its feasibility, acceptability, and preliminary utility and construct validity in an ongoing HIV-related trial.
Primary Outcome
Evaluate the acceptability of the ACASI-SHQ to clients using a modified version of the well-validated Client Satisfaction Questionnaire.
Conditions Studied
Study Locations (1)
Pennsylvania
- Treatment Research Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-04-04 |
What the finished NCT02148276 record still lists
NCT02148276 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 2 conditions, with Social Harms in Substance Users in HIV Trials appearing as the primary indexed condition, and to 0 interventions.
NCT02148276 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02148276 about?
NCT02148276 is a clinical study titled "Improving Identification of Social Harm Among Substance Abusers in HIV Trials". This two-phased project will develop a comprehensive, audio computer assisted self-administered interview social harm questionnaire (ACASI-SHQ) that will allow researchers to more easily identify and monitor social harms experienced by substance abusers participating in HIV-related trials. The ACASI...
What is the current status of trial NCT02148276?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2015-05. Estimated completion is 2017-04-04.
What conditions does trial NCT02148276 study?
This clinical trial studies the following conditions: Social Harms in Substance Users in HIV Trials, Audio Computer Assisted Self-administered Questionnaire.
Who is sponsoring clinical trial NCT02148276?
This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02148276 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia